Updates on Financial Results for March 31, 2015
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE a copy of updated Financial Results for the period ended March 31, 2015.03-07-2015
Updates on Financial Results for March 31, 2015
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE a copy of updated Financial Results for the period ended March 31, 2015.Updates
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has got renewal of HALAL CERTIFICATE from Halal Committee, Jamiat Ulama - E - Maharashtra for Ibuprofen, iso Butyl Benezene, Ethyl Acetate and other products of the Company for the year 2015-2016.It will facilitate the Company to explore the untapped export markets for its products.Outcome of the Allotment Committee Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors in its meeting held on June 29, 2015 has allotted 8,00,000 equity shares of Rs. 10/- each to M/s. Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval....Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Innova Marchantiles Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Outcome of Allotment Committee Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors in its meeting held on June 10, 2015 has allotted 5,00,000 equity shares of Rs. 10/- each to M/s. Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on July 04, 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval....Financial Results for March 31, 2015 (Standalone) (Audited)
IOL Chemicals & Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results for the period ended March 31, 2015.Outcome of Board Meeting (Code of Conduct of Fair Disclosure)
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2015, inter alia, has considered and approved the following matters :1. Appointment of Mr. Vikas Gupta as Additional and Executive Director of the Company w.e.f. May 29, 2015.2. Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information under Regulation (8) of SEBI (Prohibition of Insider Trading) Regulations, 2015....Outcome of Allotment Committee Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors in itsmeeting held on May 27, 2015 has allotted 5,00,000 equity shares of Rs. 10/- each to M/s. Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on July 04, 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval....Outcome of Allotment Committee Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors in its meeting held on May 12, 2015 has allotted 5,00,000 equity shares of Rs. 10/- each to M/s. Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on July 04, 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval....